Skip to main content
Ganesh Benzoplast Ltd. logo

Ganesh Benzoplast Ltd. — Investor Relations & Filings

Ticker · GANESHBE ISIN · INE388A01029 LEI · 335800ADMLACZ4KJML55 BSE.NS Transportation and storage
Open in API
Filings indexed 927 across all filing types
Latest filing 2024-05-21 Regulatory Filings
Country IN India
Listing BSE.NS GANESHBE

About Ganesh Benzoplast Ltd.

https://www.ganeshbenzoplast.com/

Ganesh Benzoplast Ltd. operates as an independent liquid storage tank provider and a manufacturer of specialty chemicals. The company manages a comprehensive network of bulk liquid storage terminals at major ports, offering infrastructure for the handling and storage of liquid chemicals, petroleum products, and edible oils. Its chemical manufacturing division focuses on the production of food preservatives, specifically sodium benzoate, alongside lubricant additives and plasticizers. The organization provides critical logistics support through its storage facilities and supplies chemical components to the food, automotive, and industrial sectors. By integrating port-based storage solutions with chemical production, the company maintains a significant presence in the midstream logistics and specialty chemical supply chains.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about an upcoming Board Meeting scheduled for May 30, 2024. The purpose of the meeting is to consider and approve the audited financial results for the quarter and year ended March 31, 2024. The document references compliance with SEBI Listing Regulations, specifically Regulation 29 (which pertains to Board Meeting intimation) and Regulation 33 (which relates to financial results disclosure). The document itself does not contain any financial data or results but is an announcement of the meeting where such results will be approved. The document length is short (1530 characters), and it serves as an intimation rather than the actual financial report or results. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and notification to the stock exchanges about the Board Meeting and upcoming financial results approval.
2024-05-21 English
GANESH BENZOPLAST LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve audited standalone and consolidated ...
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying them of an upcoming Board Meeting scheduled for May 30, 2024. The purpose of the meeting is to consider and approve the audited financial results for the quarter and year ended March 31, 2024. The document references compliance with SEBI Listing Regulations, specifically Regulation 29 (which pertains to Board Meeting intimation) and Regulation 33 (financial results disclosure). The document itself does not contain any financial data or results but is an announcement of the meeting where such results will be approved. The document length is short (1539 characters) and serves as a notification rather than a report or detailed filing. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and intimation to the stock exchange about the Board Meeting and upcoming financial results approval.
2024-05-21 English
Loss of Share Certificates
Share Issue/Capital Change Classification · 100% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the issuance of a duplicate share certificate under Regulation 39(3) of the Listing Regulations. It details the shareholder's name, folio number, old and new certificate numbers, distinctive numbers, and number of shares. This is a notification about a share certificate issuance, not a financial report, earnings release, or management discussion. It does not contain financial data or results, nor is it a report or presentation. It is an announcement related to share certificates, which falls under the category of Share Issue/Capital Change (SHA). The document length is short and focused on this specific corporate action.
2024-05-10 English
Intimation under regulation 39
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges and corporate services departments, informing them about the issuance of a duplicate share certificate under Regulation 39(3) of the Listing Regulations. It contains details of the shareholder, folio number, old and new certificate numbers, and the number of shares. There is no financial data, report, or analysis present. The document is an official notification related to share certificates, which fits best under Regulatory Filings (RNS) as it does not match any other specific category such as share issue announcements or capital changes (SHA) because it concerns duplicate certificates rather than new share issuance or capital restructuring.
2024-05-10 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2024-05-10 English
Cessation
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding the resignation of a non-executive director, Mr. Raunak Pilani, from the company's board. It references compliance with SEBI Listing Regulations and provides details about the resignation, including the date of cessation and reasons. There is no financial data, audit information, or report content. The document is clearly an announcement of a change in the company's board of directors, fitting the category of Board/Management Information (MANG). The document length is short and focused solely on this management change, confirming the classification.
2024-05-07 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.